Systemic inhibition of IL-6/Stat3 signalling protects against experimental osteoarthritis

2016/10/28 by Augustin Latourte, Chahrazad Cherifi, C. Cherifi +12 · 26 citations
Medicine · #Osteoarthritis Treatment and Mechanisms #Cytokine Signaling Pathways and Interactions #Rheumatoid Arthritis Research and Therapies

paper · doi:10.1136/annrheumdis-2016-209757

Cited by

• Osteoarthritis Pathophysiology
• Revisiting the Role of Interleukin-1 Pathway in Osteoarthritis: Interleukin-1α and -1β, and NLRP3 Inflammasome Are Not Involved in the Pathological Features of the Murine Menisectomy Model of Osteoarthritis. [europepmc]
• New insights on the MMP-13 regulatory network in the pathogenesis of early osteoarthritis. [europepmc]
• Glucagon-like peptide-1 receptor regulates endoplasmic reticulum stress-induced apoptosis and the associated inflammatory response in chondrocytes and the progression of osteoarthritis in rat. [europepmc]
• NF-κB Signaling Pathways in Osteoarthritic Cartilage Destruction. [europepmc]
• LDHA-mediated ROS generation in chondrocytes is a potential therapeutic target for osteoarthritis. [europepmc]
• Musculoskeletal Consequences of COVID-19. [europepmc]
• A roadmap to target interleukin-6 in osteoarthritis. [europepmc]
• Knee Osteoarthritis: A Review of Pathogenesis and State-Of-The-Art Non-Operative Therapeutic Considerations. [europepmc]
• Oxidative stress and inflammation in osteoarthritis pathogenesis: Role of polyphenols. [europepmc]
• Osteoclast-associated receptor blockade prevents articular cartilage destruction via chondrocyte apoptosis regulation. [europepmc]
• JUNB-FBXO21-ERK axis promotes cartilage degeneration in osteoarthritis by inhibiting autophagy. [europepmc]
• Proinflammatory T cell polarization is already present in patients with early knee osteoarthritis. [europepmc]
• Excavating bioactivities of nanozyme to remodel microenvironment for protecting chondrocytes and delaying osteoarthritis. [europepmc]
• Amniotic membrane-mesenchymal stromal cells secreted factors and extracellular vesicle-miRNAs: Anti-inflammatory and regenerative features for musculoskeletal tissues. [europepmc]
• Promising targets for therapy of osteoarthritis: a review on the Wnt and TGF-β signalling pathways. [europepmc]
• TRPV1 alleviates osteoarthritis by inhibiting M1 macrophage polarization via Ca 2+ /CaMKII/Nrf2 signaling pathway. [europepmc]
• circPDE4B prevents articular cartilage degeneration and promotes repair by acting as a scaffold for RIC8A and MID1. [europepmc]
• 14-3-3 epsilon is an intracellular component of TNFR2 receptor complex and its activation protects against osteoarthritis. [europepmc]
• The Development of Disease-Modifying Therapies for Osteoarthritis (DMOADs): The Evidence to Date. [europepmc]
• ADAMTS5 in Osteoarthritis: Biological Functions, Regulatory Network, and Potential Targeting Therapies. [europepmc]
• Cytokines and Chemokines Involved in Osteoarthritis Pathogenesis. [europepmc]
• Synovial inflammation in osteoarthritis progression. [europepmc]
• Interleukin-6 signaling mediates cartilage degradation and pain in posttraumatic osteoarthritis in a sex-specific manner. [europepmc]
• Exosomes rewire the cartilage microenvironment in osteoarthritis: from intercellular communication to therapeutic strategies. [europepmc]
• Regulation and therapy, the role of JAK2/STAT3 signaling pathway in OA: a systematic review. [europepmc]